Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
BMC Gastroenterol 25 , 150 (2025)
Where Semaglutide targets a single receptor and Tirzepatide hits two, Retatrutide simultaneously activates three: GLP-1 (Glucagon-Like Peptide-1): The foundational receptor target for this entire class
Skin Pals, Health Pals, Pill Pals, and various other terms and services are trademarks of The Health Pals Company, LLC
You're more likely to benefit if: You feel heavy specifically after higher-fat meals (lipase may help with fat digestion) You get gas or bloating after dairy (lactase may help if lactose is the trigger) You notice predictable bloating after beans, certain vegetables, or starch-heavy meals (some blends include enzymes aimed at complex carbs) You can eat a small, protein-forward meal but feel uncomfortable when the protein is denser (protease support may help) A GLP-1-friendly way to interpret "success" is modest: less post-meal pressure, less burping, less gassiness, and a smoother digestion experience
Dual and triple agonists Tirzepatide is the first dual GIP/GLP-1 receptor agonist
